申请人:The United States of America as represented by the Secretary of the
公开号:US05190969A1
公开(公告)日:1993-03-02
The present invention is related to compounds, compositions and methods of treating viral infections. Compounds of the present invention have the following general formula: ##STR1## wherein R is selected from --CH.sub.2 OH, --CO.sub.2 R.sup.2, --CONR.sup.3 R.sup.4, or COR.sup.5, wherein R.sup.2 is hydrogen or a lower alkyl group, R.sup.3 and R.sup.4 are each independently hydrogen or a lower alkyl group, R.sup.5 is an amino acid residue bound via a terminal nitrogen or peptide having at least two amino acid residues; and wherein R.sup.1 is C.sub.5 -C.sub.13 alkyl, aryl, aralkyl, aralkyl(lower alkyl) ether, or C.sub.5 -C.sub.13 alkyl (lower alkyl)ether.
本发明涉及化合物、组合物和治疗病毒感染的方法。本发明的化合物具有以下一般式:##STR1## 其中R从--CH.sub.2 OH,--CO.sub.2 R.sup.2,--CONR.sup.3 R.sup.4或COR.sup.5中选择,其中R.sup.2是氢或较低的烷基基团,R.sup.3和R.sup.4分别独立地是氢或较低的烷基基团,R.sup.5是通过末端氮原子结合的氨基酸残基或至少具有两个氨基酸残基的肽;其中R.sup.1为C.sub.5 -C.sub.13烷基,芳基,芳基烷基,芳基烷基(较低烷基)醚,或C.sub.5 -C.sub.13烷基(较低烷基)醚。